WJA
IDXX icon

Willis Johnson & Associates’s Idexx Laboratories IDXX Stock Holding History

Willis Johnson & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-660
Closed -$435K – 105
2021
Q4 		$435K Sell
660
-2
-0.3% -$1.26K 0.06% 65
2021
Q3 		$412K Hold
662
– – 0.06% 64
2021
Q2 		$418K Buy
662
+2
+0.3% +$1.1K 0.06% 61
2021
Q1 		$323K Buy
660
+10
+2% +$5.01K 0.05% 67
2020
Q4 		$325K Buy
+650
New +$291K 0.05% 59

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Willis Johnson & Associates's IDXX Position: Q1 2022 in Review

Willis Johnson & Associates sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 660 shares — an estimated $435K sold.

Willis Johnson & Associates first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $435K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Willis Johnson & Associates reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Willis Johnson & Associates sold 660 Idexx Laboratories shares in Q1 2022, an estimated $435K.
  • Willis Johnson & Associates first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
  • Willis Johnson & Associates's Idexx Laboratories position peaked at $435K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Willis Johnson & Associates's 13F filing for Q1 2022, filed 10 May 2022.